S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
pixel
pixel
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
pixel
pixel
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
pixel
pixel
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
pixel
pixel
Log in
NASDAQ:AMTI

Applied Molecular Transport Stock Forecast, Price & News

$59.64
+1.00 (+1.71 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$54.55
Now: $59.64
$61.95
50-Day Range
$33.18
MA: $45.54
$68.66
52-Week Range
$17.05
Now: $59.64
$77.03
Volume173,987 shs
Average Volume91,362 shs
Market Capitalization$2.08 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its lead product candidate is AMT-101, an oral gastrointestinal (GI) selective interleukin 10 that has completed a Phase 1b clinical trial in patients with ulcerative colitis (UC). The company, through its technology platform designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and RNA therapeutics. In addition, it engages in the development of AMT-126, a GI-selective oral fusion of rhIL-22 for diseases related to intestinal epithelium barrier function defects. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.
Applied Molecular Transport logo

Headlines

Applied Molecular Transport Inc
January 21, 2021 |  bloomberg.com
See More Headlines

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AMTI
CUSIPN/A
CIKN/A
Phone650-392-0420
Employees64
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$2.08 billion
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

1.33 out of 5 stars

Medical Sector

715th out of 1,969 stocks

Pharmaceutical Preparations Industry

345th out of 772 stocks

Analyst Opinion: 1.5Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -
$59.64
+1.00 (+1.71 %)
(As of 03/4/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive AMTI News and Ratings via Email

Sign-up to receive the latest news and ratings for AMTI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Applied Molecular Transport (NASDAQ:AMTI) Frequently Asked Questions

Is Applied Molecular Transport a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Applied Molecular Transport in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Applied Molecular Transport stock.
View analyst ratings for Applied Molecular Transport
or view top-rated stocks.

What stocks does MarketBeat like better than Applied Molecular Transport?

Wall Street analysts have given Applied Molecular Transport a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Applied Molecular Transport wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Applied Molecular Transport's earnings last quarter?

Applied Molecular Transport Inc. (NASDAQ:AMTI) announced its quarterly earnings data on Tuesday, November, 17th. The company reported ($0.48) EPS for the quarter, missing the Zacks' consensus estimate of ($0.41) by $0.07.
View Applied Molecular Transport's earnings history
.

What price target have analysts set for AMTI?

3 equities research analysts have issued 12-month price targets for Applied Molecular Transport's stock. Their forecasts range from $34.00 to $74.00. On average, they anticipate Applied Molecular Transport's stock price to reach $48.67 in the next year. This suggests that the stock has a possible downside of 18.4%.
View analysts' price targets for Applied Molecular Transport
or view top-rated stocks among Wall Street analysts.

Who are Applied Molecular Transport's key executives?

Applied Molecular Transport's management team includes the following people:
  • Dr. Tahir Mahmood, Co-Founder, CEO & Director (Age 46, Pay $349.28k)
  • Dr. Randall Mrsny Ph.D., Co-Founder, Chief Scientific Officer & Director (Age 66)
  • Mr. Brandon Hants, VP of Fin. & Bus. Operations and Principal Accounting Officer (Age 44, Pay $317.71k)
  • Dr. Bittoo Kanwar M.D., Chief Medical Officer (Age 45, Pay $403.6k)
  • Mr. Shawn M. Cross, Chief Financial Officer (Age 53)
  • Dr. Charles V. Olson, Sr. VP of Operations (Age 64)
  • Mr. Douglas A. Rich M.B.A., M.B.A, Chief Technical Officer (Age 52)
  • Mr. Andrew H. Chang, Head of Investor Relations & Corp. Communications
  • Dr. Andy Whitney Ph.D., VP and Head of Preclinical Devel. & Translational Science (Age 59)
  • Ms. Elizabeth Bhatt, Chief Bus. & Strategy Officer (Age 53)

Who are some of Applied Molecular Transport's key competitors?

What other stocks do shareholders of Applied Molecular Transport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied Molecular Transport investors own include Honeywell International (HON), CVS Health (CVS), The Home Depot (HD), The Procter & Gamble (PG), Raytheon Technologies (RTX), Thermo Fisher Scientific (TMO), Alibaba Group (BABA), Cisco Systems (CSCO), Johnson & Johnson (JNJ) and Resideo Technologies (REZI).

When did Applied Molecular Transport IPO?

(AMTI) raised $130 million in an IPO on Friday, June 5th 2020. The company issued 10,000,000 shares at a price of $12.00-$14.00 per share. BofA Securities, Jefferies and SVB Leerink served as the underwriters for the IPO.

What is Applied Molecular Transport's stock symbol?

Applied Molecular Transport trades on the NASDAQ under the ticker symbol "AMTI."

Who are Applied Molecular Transport's major shareholders?

Applied Molecular Transport's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Founders Fund V Management LLC (10.35%), BlackRock Inc. (3.89%), Northern Trust Corp (0.52%), Burleson & Company LLC (0.34%), Nuveen Asset Management LLC (0.14%) and Bank of New York Mellon Corp (0.14%).

Which major investors are selling Applied Molecular Transport stock?

AMTI stock was sold by a variety of institutional investors in the last quarter, including Northern Trust Corp, Wells Fargo & Company MN, and American International Group Inc..

Which major investors are buying Applied Molecular Transport stock?

AMTI stock was bought by a variety of institutional investors in the last quarter, including Founders Fund V Management LLC, BlackRock Inc., Swiss National Bank, State of Wisconsin Investment Board, Bank of New York Mellon Corp, Credit Suisse AG, Virtus ETF Advisers LLC, and ProShare Advisors LLC.

How do I buy shares of Applied Molecular Transport?

Shares of AMTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Applied Molecular Transport's stock price today?

One share of AMTI stock can currently be purchased for approximately $59.64.

How much money does Applied Molecular Transport make?

Applied Molecular Transport has a market capitalization of $2.08 billion.

How many employees does Applied Molecular Transport have?

Applied Molecular Transport employs 64 workers across the globe.

What is Applied Molecular Transport's official website?

The official website for Applied Molecular Transport is www.appliedmt.com.

Where are Applied Molecular Transport's headquarters?

Applied Molecular Transport is headquartered at 1 TOWER PLACE SUITE 850, SOUTH SAN FRANCISCO CA, 94080.

How can I contact Applied Molecular Transport?

Applied Molecular Transport's mailing address is 1 TOWER PLACE SUITE 850, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 650-392-0420.


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.